Initiate Phase 1b/2 trial for CKD Anemia
Delivered after the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 10 Aug 2022
- Due
- 31 Dec 2022
- Delivered
- February 2023
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Expect to initiate Phase 1b / 2 trial by YE’22”
What we found
Evidence strength A What the grades mean
The company committed to initiating the Phase 1b/2 trial for CKD anemia by the end of 2022, but the trial was not initiated until February 2023.
-
A Disc Medicine, Inc. 10-K filed 2023-03-31
“initiated a separate Phase 1b/2 clinical trial in February 2023 in patients with non-dialysis dependent CKD and anemia.” ✓ confirmed on the page
Market reaction: the shares moved -5.2% against the S&P 500 over the three sessions around the disclosure (30 Mar 2023 to 4 Apr 2023). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Initiate
- Deliverable
- Phase 1b/2 trial for CKD Anemia
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Met”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the recorded outcome.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Disc Medicine, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2022-IRON-002109 · Corrections policy